Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF-VEGFR-2 Signaling

被引:231
作者
Sison, Karen [1 ]
Eremina, Vera [1 ]
Baelde, Hans [2 ]
Min, Wang [3 ]
Hirashima, Masanori [4 ]
Fantus, I. George [1 ]
Quaggin, Susan E. [1 ,5 ]
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3H7, Canada
[2] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[3] Yale Univ, Dept Pathol, Vasc Biol & Therapeut Program, New Haven, CT USA
[4] Kobe Univ, Dept Physiol & Cell Biol, Kobe, Hyogo 657, Japan
[5] Univ Toronto, St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 21卷 / 10期
关键词
ENDOTHELIAL GROWTH-FACTOR; VEGF-A EXPRESSION; GENE-EXPRESSION; PODOCYTES; MICE; NEUROPILIN-1; RECEPTORS; SURVIVAL; DISEASES; FAMILY;
D O I
10.1681/ASN.2010030295
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
VEGF is a potent vascular growth factor produced by podocytes in the developing and mature glomerulus. Specific deletion of VEGF from podocytes causes glomerular abnormalities including profound endothelial cell injury, suggesting that paracrine signaling is critical for maintaining the glomerular filtration barrier (GFB). However, it is not clear whether normal GFB function also requires autocrine VEGF signaling in podocytes. In this study, we sought to determine whether an autocrine VEGF-VEGFR-2 loop in podocytes contributes to the maintenance of the GFB in vivo. We found that induced, whole-body deletion of VEGFR-2 caused marked abnormalities in the kidney and also other tissues, including the heart and liver. By contrast, podocyte-specific deletion of the VEGFR-2 receptor had no effect on glomerular development or function even up to 6 months old. Unlike cell culture models, enhanced expression of VEGF by podocytes in vivo caused foot process fusion and alterations in slit diaphragm-associated proteins; however, inhibition of VEGFR-2 could not rescue this defect. Although VEGFR-2 was dispensable in the podocyte, glomerular endothelial cells depended on VEGFR-2 expression: postnatal deletion of the receptor resulted in global defects in the glomerular microvasculature. Taken together, our results provide strong evidence for dominant actions of a paracrine VEGF-VEGFR-2 signaling loop both in the developing and in the filtering glomerulus. VEGF produced by the podocyte regulates the structure and function of the adjacent endothelial cell.
引用
收藏
页码:1691 / 1701
页数:11
相关论文
共 35 条
  • [1] Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung
    Akeson, AL
    Greenberg, JM
    Cameron, JE
    Thompson, FY
    Brooks, SK
    Wiginton, D
    Whitsett, JA
    [J]. DEVELOPMENTAL BIOLOGY, 2003, 264 (02) : 443 - 455
  • [2] Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
    Albuquerque, Romulo J. C.
    Hayashi, Takahiko
    Cho, Won Gil
    Kleinman, Mark E.
    Dridi, Sami
    Takeda, Atsunobu
    Baffi, Judit Z.
    Yamada, Kiyoshi
    Kaneko, Hiroki
    Green, Martha G.
    Chappell, Joe
    Wilting, Joerg
    Weich, Herbert A.
    Yamagami, Satoru
    Amano, Shiro
    Mizuki, Nobuhisa
    Alexander, Jonathan S.
    Peterson, Martha L.
    Brekken, Rolf A.
    Hirashima, Masanori
    Capoor, Seema
    Usui, Tomohiko
    Ambati, Balamurali K.
    Ambati, Jayakrishna
    [J]. NATURE MEDICINE, 2009, 15 (09) : 1023 - U74
  • [3] Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction
    Belteki, G
    Haigh, J
    Kabacs, N
    Haigh, K
    Sison, K
    Costantini, F
    Whitsett, J
    Quaggin, SE
    Nagy, A
    [J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (05) : 1 - 10
  • [4] The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGFxxxb in Human Kidney Development
    Bevan, Heather S.
    van den Akker, Nynke M. S.
    Qiu, Yan
    Polman, Japke A. E.
    Foster, Rebecca R.
    Yem, Justin
    Nishikawa, Ali
    Satchell, Simon C.
    Harper, Steven J.
    Groot, Adriana C. Gittenberger-de
    Bates, David O.
    [J]. NEPHRON PHYSIOLOGY, 2008, 110 (04): : 57 - 67
  • [5] Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes
    Bortoloso, E
    Del Prete, D
    Vestra, MD
    Gambaro, G
    Saller, A
    Antonucci, F
    Baggio, B
    Anglani, F
    Fioretto, P
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (06) : 799 - 807
  • [6] Podocyte-derived vascular endothelial growth factor mediates the stimulation of α3(IV) collagen production by transforming growth factor-β 1 in mouse podocytes
    Chen, S
    Kasama, Y
    Lee, JS
    Jim, B
    Marin, M
    Ziyadeh, FN
    [J]. DIABETES, 2004, 53 (11) : 2939 - 2949
  • [7] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
    Cooper, ME
    Vranes, D
    Youssef, S
    Stacker, SA
    Cox, AJ
    Rizkalla, B
    Casley, DJ
    Bach, LA
    Kelly, DJ
    Gilbert, RE
    [J]. DIABETES, 1999, 48 (11) : 2229 - 2239
  • [8] Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout miceLE
    Cui, SY
    Li, CJ
    Ema, M
    Weinstein, J
    Quaggin, SE
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3247 - 3255
  • [9] Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors
    Ema, M
    Takahashi, S
    Rossant, J
    [J]. BLOOD, 2006, 107 (01) : 111 - 117
  • [10] Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases
    Eremina, V
    Sood, M
    Haigh, J
    Nagy, A
    Lajoie, G
    Ferrara, N
    Gerber, HP
    Kikkawa, Y
    Miner, JH
    Quaggin, SE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) : 707 - 716